Product Portfolio
Tirzepatide is a dual GIP/GLP-1 receptor agonist with rapidly growing global demand in diabetes and obesity treatment markets. For generic pharmaceutical companies and CDMOs, selecting a high-quality, regulatory-ready API supplier is essential to ensure successful development and approval.
We provide high-purity Tirzepatide API with controlled impurity profile, supported by a DMF under preparation, designed to meet FDA and EMA expectations and minimize CMC risks.
For generic pharmaceutical companies and CDMOs, the key to a successful Semaglutide project lies in regulatory readiness, impurity control, and supplier reliability.
We offer high-purity Semaglutide API with a well-controlled impurity profile, supported by a DMF currently under preparation, designed to meet FDA and EMA expectations and reduce CMC-related risks during review.
Built for partners who prioritize faster approval, lower risk, and consistent quality
Recombinant Human Growth Hormone (rhGH) is a well-established biopharmaceutical widely used in the treatment of growth hormone deficiency and related disorders. As global demand for biologics continues to rise, rhGH remains a key product in both innovator and biosimilar markets.
For pharmaceutical manufacturers, sourcing high-quality rhGH API is critical to ensuring product efficacy, safety, and regulatory compliance.
